Creating A Business Case for Cancer Control in Wyoming

1
Creating A Business Case for Cancer Control in
Wyoming

• Kimberly Rogers
• Wyoming Comprehensive Cancer Control Program
  Manager
• Wyoming Department of Health
• [phone]

2
What is the burden of cancer in Wyoming?

• In 2003, a total of 2,241 new cancer cases were
  reported in Wyoming. In addition, in 2003, a
  total of 935 Wyoming people died as a result of
  cancer
• ACS estimates 2,500 new cancer cases will be
  diagnosed and 1,110 Wyoming people will die of
  the disease in 2006.

3
Top 5 Cancer SitesIncidence Mortality (2003)
Cervical Cancer data is challenging because
only invasive cancers are reportable. Thus the
number of pre-cancerous and in-situ cancers is
unknown. The WBCCEDP funded 897 Pap tests in
2004. Although no cervical cancer cases were
diagnosed, 41 pre-cancer cases were identified
and treated. 65 of these women were between
the ages of 20-30 years old.
4
What is the estimated financial impact of cancer
in Wyoming ?
The above estimates were calculated and
projected based on national data provided in The
Cancer Atlas, a publication by the American
Cancer Society, US Department of Health Human
Services, Centers for Disease Control
Prevention, World Health Organization the UICC.
5
Direct Cost vs. Indirect Cost Estimate in Wyoming

• Direct Indirect Total
• 127,145,247 233,506,097 360,651,344

Direct Costs Payments and resources utilized
for treatment, care and rehabilitation directly
related to the illness. Indirect Costs Loss of
economic output due to days off work and
premature death. Also included in this estimate
are hidden costs such as health insurance
premiums, and non-medical expenses
(transportation, wigs, child or elder care,
housekeeping assistance, ostomy supplies,
prostheses).
6
Is Early Detection Cost Effective?

• Milliman Report, 2005
• Report presents estimated costs and benefits of
  prevention, cancer screening / early detection
  for employee benefit programs.
• Focuses on breast, cervical, and colorectal
  cancer screening (USPSTF has established
  evidence-based screening methods)
• Focuses on prostate screening ONLY because it is
  covered in most health plans.

7
Findings of report

• Cancer Prevention and Early Detection is Low
  Cost
• The Cost of People with Cancer is High
• Medical costs
• Lost productivity
• Short and long term disability
• Life insurance
• Investment in Prevention and Early Detection
  Makes Financial Sense.

8
Screening Costs PMPM
Table 1 Screening Costs PMPM with 100
Compliance for a Typical Employer
9
Table 2 Current Spending on Elective Prostate
Cancer Screening
10

• People with cancer only represent about 1.6 of
  the commercial population but generate about 10
  of an employer/insurers annual medical claim
  costs.

11
Table 4 Comparing Costs of People with Cancer
to People without Cancer
12
(No Transcript)
13
The Bottom Line

• Estimated cost of direct and indirect costs of
  treatment in Wyoming far exceeds the cost of
  prevention and early detection of cancer
• Early screening suggests a greater opportunity
  for less aggressive and costly treatment
• The investment we make in CCC is a long-term
  investment and will contribute to overall health
  and well-being in Wyoming.

14
Utilizing a comprehensive multi-level systems
approach to communicate CCC business case at a
grassroots level.